Quantitative analysis for Galecto, Inc. (DMRA) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (52.0) (grade C). 25 signals analyzed (21 differentiated alt-data).
DMRA stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $26.09 | $24.17 | $24.23 |
| 2026-05-08 | $25.30 | $23.96 | $24.16 |
| 2026-05-20 | $24.83 | $24.00 | $24.15 |
| 2026-06-02 | $25.45 | $22.92 | $22.95 |
| 2026-06-12 | $21.89 | $20.49 | $20.78 |
| 2026-06-25 | $23.96 | $21.69 | $22.57 |
| 2026-07-08 | $30.35 | $27.18 | $27.53 |
| 2026-07-20 | $34.89 | $31.48 | $33.38 |
| 2026-07-30 | $30.02 | $28.71 | $29.21 |
| 2026-08-12 | $31.52 | $29.89 | $31.00 |
| 2026-08-24 | $31.49 | $29.70 | $30.31 |
| 2026-09-03 | $28.59 | $27.40 | $28.00 |
How Galecto, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| IMCR | Immunocore Holdings plc | $1.5B | — |
| IMTX | Immatics N.V. | $1.5B | — |
| ATAI | Atai Beckley N.V | $1.5B | — |
| ABCL | AbCellera Biologics Inc. | $1.4B | — |
View all Health Care stocks by valuation and signals →
Galecto, Inc. (DMRA) scores Hold (52.0), and the composite conceals a 89-point disagreement between its dimensions. It is strongest on analyst consensus at 90, and weakest on competitive moat at 1. A stock can carry analyst consensus that high while competitive moat sits at 1; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 90 |
| technicals | 57 |
| competitive moat | 1 |
StoQuant analyzes 25 signals (21 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Galecto, Inc. (DMRA): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/DMRA"><img src="https://stoquant.com/badge/DMRA.svg" alt="Galecto, Inc. (DMRA) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.